Probing the inhibitory activity of epigallocatechin-gallate on toxic aggregates of mutant (L84F) SOD1 protein through geometry based sampling and steered molecular dynamics.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Journal of Molecular Graphics and Modelling

• Publication date

  2017-06-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.jmgm.2017.04.019PMID 28458007
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• ALS-linked misfolded SOD1 species have divergent impacts on mitochondria

  2016cited by this paper
• Molecular Dynamics Study on the Inhibition Mechanisms of Drugs CQ1-3 for Alzheimer Amyloid-β40 Aggregation Induced by Cu(2.).

  2016cited by this paper
• Efficient Inhibition of Protein Aggregation, Disintegration of Aggregates, and Lowering of Cytotoxicity by Green Tea Polyphenol-Based Self-Assembled Polymer Nanoparticles.

  2016cited by this paper
• Identification of L84F mutation with a novel nucleotide change c.255G > T in the superoxide dismutase gene in a North Indian family with amyotrophic lateral sclerosis

  2016cited by this paper
• Opposite Structural Effects of Epigallocatechin-3-gallate and Dopamine Binding to α-Synuclein.

  2016cited by this paper
• Critical Nucleus Structure and Aggregation Mechanism of the C-terminal Fragment of Copper-Zinc Superoxide Dismutase Protein.

  2016cited by this paper
• Bioactive polyphenol interactions with β amyloid: a comparison of binding modelling, effects on fibril and aggregate formation and neuroprotective capacity.

  2016cited by this paper
• Structural investigation on the electrostatic loop of native and mutated SOD1 and their interaction with therapeutic compounds

  2015cited by this paper
• Structural Properties of Green Tea Catechins.

  2015cited by this paper
• PubChem Substance and Compound databases

  2015cited by this paper
• Role of the Flavan-3-ol and Galloyl Moieties in the Interaction of (−)-Epigallocatechin Gallate with Serum Albumin

  2014cited by this paper
• Steered Molecular Dynamics Simulations for Studying Protein-Ligand Interaction in Cyclin-Dependent Kinase 5

  2014cited by this paper
• Free energy landscapes for initiation and branching of protein aggregation

  2013cited by this paper
• Aggregation-triggering segments of SOD1 fibril formation support a common pathway for familial and sporadic ALS

  2013cited by this paper
• Structural similarity of wild-type and ALS-mutant superoxide dismutase-1 fibrils using limited proteolysis and atomic force microscopy

  2013cited by this paper
• Analysis of the inhibition and remodeling of islet amyloid polypeptide amyloid fibers by flavanols.

  2012cited by this paper
• Site specific interaction of the polyphenol EGCG with the SEVI amyloid precursor peptide PAP(248-286).

  2012cited by this paper
• Inhibition of aggregation of amyloid peptides by beta-sheet breaker peptides and their binding affinity.

  2011cited by this paper
• Molecular insight into conformational transition of amyloid β-peptide 42 inhibited by (-)-epigallocatechin-3-gallate probed by molecular simulations.

  2011cited by this paper
• Roles of zinc and copper in modulating the oxidative refolding of bovine copper, zinc superoxide dismutase.

  2010cited by this paper
• (-)-epigallocatechin-3-gallate (EGCG) maintains kappa-casein in its pre-fibrillar state without redirecting its aggregation pathway.

  2009cited by this paper
• AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility

  2009cited by this paper
• Folding versus aggregation: Polypeptide conformations on competing pathways

  2008cited by this paper
• SOD1 and Amyotrophic Lateral Sclerosis: Mutations and Oligomerization

  2008cited by this paper
• EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers

  2008cited by this paper
• ALSOD: The Amyotrophic Lateral Sclerosis Online Database

  2008cited by this paper
• GROMACS 4:  Algorithms for Highly Efficient, Load-Balanced, and Scalable Molecular Simulation.

  2008cited by this paper
• The Threat of Instability: Neurodegeneration Predicted by Protein Destabilization and Aggregation Propensity

  2008cited by this paper
• Small molecule inhibitors of alpha-synuclein filament assembly.

  2006cited by this paper
• Protein misfolding, functional amyloid, and human disease.

  2006cited by this paper
• The effect of epigallocatechin gallate on suppressing disease progression of ALS model mice.

  2006cited by this paper
• Small Molecule Inhibitors of α-Synuclein Filament Assembly†

  2006cited by this paper
• Copper-zinc superoxide dismutase and amyotrophic lateral sclerosis.

  2005cited by this paper
• Development and testing of a general amber force field

  2004cited by this paper
• Neurological mechanisms of green tea polyphenols in Alzheimer's and Parkinson's diseases.

  2004cited by this paper
• Green tea polyphenols and cancer chemoprevention: multiple mechanisms and endpoints for phase II trials.

  2004cited by this paper
• SOD1 activity and protective factors in familial ALS patients with L84F SOD1 mutation

  2002cited by this paper
• Structure and dynamics of copper‐free SOD: The protein before binding copper

  2002cited by this paper
• Swiss-PDB Viewer (Deep View).

  2001cited by this paper
• Copper chaperone for superoxide dismutase co-aggregates with superoxide dismutase 1 (SOD1) in neuronal Lewy body-like hyaline inclusions: an immunohistochemical study on familial amyotrophic lateral sclerosis with SOD1 gene mutation

  2001cited by this paper
• Cancer chemoprevention by tea polyphenols.

  2000cited by this paper
• Clustering of ALS patients in central Italy due to the occurrence of the L84F SOD1 gene mutation

  1999cited by this paper
• Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function

  1998cited by this paper
• The chemistry of tea flavonoids.

  1997cited by this paper
• Particle mesh Ewald: An N⋅log(N) method for Ewald sums in large systems

  1993cited by this paper
• The biology of oxygen radicals.

  1978cited by this paper

• Understanding Structural Destabilization and Amyloid Aggregation in ALS-Related Neurodegenerative Disorder: An In Silico and Experimental Analysis of SOD1 Variants.

  2025cites this paper
• Inhibitory effect of Fisetin against the aggregation process of SOD1 E100K mutant: computer-based drug design as a potential therapeutic for ALS disease

  2025cites this paper
• Discovery of New Heteroaryldihydropyrimidine Compounds as HBV Capsid Protein Inhibitors Based on QSAR, Molecular Docking and Molecular Dynamics Simulations**

  2024cites this paper
• Dietary polyphenols represent a phytotherapeutic alternative for gut dysbiosis associated neurodegeneration: A Systematic review.

  2024cites this paper
• Potential Correlation between Tea Intake and the Risk of Amyotrophic Lateral Sclerosis: A Mendelian Randomization Study

  2024cites this paper
• Nutritional and Microbiota-Based Approaches in Amyotrophic Lateral Sclerosis: From Prevention to Treatment

  2024cites this paper
• Exploring the anti-amyloid potential of salvianolic acid A against the ALS-associated mutant SOD1: insights from molecular docking and molecular dynamic simulations

  2024cites this paper
• Insights on Natural Products Against Amyotrophic Lateral Sclerosis (ALS)

  2023cites this paper
• Theoretical investigations of TTR derived aggregation-prone peptides’ potential to biochemically attenuate the amyloidogenic propensities of V30 M TTR amyloid fibrils

  2023cites this paper
• Fighting against amyotrophic lateral sclerosis (ALS) with flavonoids: a computational approach to inhibit superoxide dismutase (SOD1) mutant aggregation

  2023cites this paper
• Discovery of novel BRD4-BD2 inhibitors via in silico approaches: QSAR techniques, molecular docking, and molecular dynamics simulations

  2023cites this paper
• Polyphenolic flavonoid compounds act as the inhibitory potential of aggregation process: Implications for the prevention and therapeutics against FALS-associated D101G SOD1 mutant

  2023cites this paper
• Impact of Plant-Derived Compounds on Amyotrophic Lateral Sclerosis

  2023cites this paper
• Comparative analyses and molecular videography of MD simulations on WT human SOD1

  2022cites this paper
• Advances in the understanding of protein misfolding and aggregation through molecular dynamics simulation.

  2022cites this paper
• Oxidative Stress in Tauopathies: From Cause to Therapy

  2022cites this paper
• Probing the polyphenolic flavonoid, morin as a highly efficacious inhibitor against amyloid(A4V) mutant SOD1 in fatal amyotrophic lateral sclerosis.

  2022cites this paper
• Antioxidant Therapy in Oxidative Stress-Induced Neurodegenerative Diseases: Role of Nanoparticle-Based Drug Delivery Systems in Clinical Translation

  2022cites this paper
• Decoding Conformational Imprint of Convoluted Molecular Interactions Between Prenylflavonoids and Aggregated Amyloid-Beta42 Peptide Causing Alzheimer’s Disease

  2021cites this paper
• Amyloid Oligomers: A Joint Experimental/Computational Perspective on Alzheimer's Disease, Parkinson's Disease, Type II Diabetes, and Amyotrophic Lateral Sclerosis.

  2021cites this paper
• The Impact of Microbiota on the Pathogenesis of Amyotrophic Lateral Sclerosis and the Possible Benefits of Polyphenols. An Overview

  2021cites this paper
• Plant-Derived Natural Compounds for the Treatment of Amyotrophic Lateral Sclerosis: An Update

  2021cites this paper
• Coffee and Tea Consumption Impact on Amyotrophic Lateral Sclerosis Progression: A Multicenter Cross-Sectional Study

  2021cites this paper
• Therapeutic Potential of Polyphenols in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia

  2021cites this paper
• Molecular simulation probes the potency of resveratrol in regulating the toxic aggregation of mutant V30M TTR fibrils in Transthyretin mediated amyloidosis.

  2021cites this paper
• Methylene blue inhibits nucleation and elongation of SOD1 amyloid fibrils

  2020cites this paper
• Nanoparticle-based delivery of polyphenols for the treatment of inflammation-associated diseases

  2020cites this paper
• The Aggregation Conditions Define Whether EGCG is an Inhibitor or Enhancer of α-Synuclein Amyloid Fibril Formation

  2020cites this paper
• Identifying Insulin Fibril Conformational Differences by Thioflavin-T Binding Characteristics

  2020cites this paper
• Computational Investigation on Electrostatic Loop Mutants Instigating Destabilization and Aggregation on Human SOD1 Protein Causing Amyotrophic Lateral Sclerosis

  2019cites this paper
• Molecular binding response of naringin and naringenin to H46R mutant SOD1 protein in combating protein aggregation using density functional theory and discrete molecular dynamics.

  2019cites this paper
• Allura red rapidly induces amyloid-like fibril formation in hen egg white lysozyme at physiological pH.

  2019cites this paper
• The Environment Is a Key Factor in Determining the Anti-Amyloid Efficacy of EGCG

  2019cites this paper
• Molecular mechanics and quantum chemical calculations unveil the combating effect of baicalein on human islet amyloid polypeptide aggregates

  2019cites this paper
• Rational design of linear tripeptides against the aggregation of human mutant SOD1 protein causing amyotrophic lateral sclerosis.

  2019cites this paper
• Comparative binding of kaempferol and kaempferide on inhibiting the aggregate formation of mutant (G85R) SOD1 protein in familial amyotrophic lateral sclerosis: A quantum chemical and molecular mechanics study

  2018cites this paper
• Computational Molecular Docking and X-ray Crystallographic Studies of Catechins in New Drug Design Strategies

  2018cites this paper